Francisco, Jenelyn .

HRN: 28-62-35  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/03/2026
03/10/2026
IV
650 Mg
Q12
DM Foot
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  BloodstreamBone & Joint    Compliance to guidelines: Compliant To Guidelines